150 related articles for article (PubMed ID: 2149285)
21. Development and biochemical pharmacology of toremifene, an antiestrogenic antitumor drug.
Kangas L
Acta Obstet Gynecol Scand; 1991; 70(4-5):399. PubMed ID: 1836089
[No Abstract] [Full Text] [Related]
22. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
di Salle E; Zaccheo T; Ornati G
J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
[TBL] [Abstract][Full Text] [Related]
23. Introduction to toremifene.
Kangas L
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S3-7. PubMed ID: 2149282
[TBL] [Abstract][Full Text] [Related]
24. [Breast cancer--tamoxifen and tamoxifen analogues for the treatment of breast cancer].
Iino Y; Morishita Y
Nihon Rinsho; 1994 Mar; 52(3):797-803. PubMed ID: 8164385
[TBL] [Abstract][Full Text] [Related]
25. Phase II experience with toremifene in the treatment of ER-positive breast cancer of postmenopausal women.
Valavaara R
Cancer Invest; 1990; 8(2):275-6. PubMed ID: 2144787
[No Abstract] [Full Text] [Related]
26. A phase I study of toremifene.
Tominaga T; Abe O; Izuo M; Nomura Y
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S27-9. PubMed ID: 2149281
[TBL] [Abstract][Full Text] [Related]
27. Droloxifene, a new antiestrogen, in advanced breast cancer. A double-blind dose-finding study. The Droloxifene 002 International Study Group.
Deschênes L
Am J Clin Oncol; 1991; 14 Suppl 2():S52-5. PubMed ID: 1962599
[TBL] [Abstract][Full Text] [Related]
28. Phase I trial of droloxifene in patients with metastatic breast cancer.
Buzdar AU; Kau S; Hortobagyi GN; Theriault RL; Booser D; Holmes FA; Walters R; Krakoff IH
Cancer Chemother Pharmacol; 1994; 33(4):313-6. PubMed ID: 8281625
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer.
Wiebe VJ; Benz CC; Shemano I; Cadman TB; DeGregorio MW
Cancer Chemother Pharmacol; 1990; 25(4):247-51. PubMed ID: 2136809
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment.
Jönsson PE; Malmberg M; Bergljung L; Ingvar C; Ericsson M; Ryden S; Nilsson I; Terje IJ
Anticancer Res; 1991; 11(2):873-5. PubMed ID: 1829600
[TBL] [Abstract][Full Text] [Related]
31. Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: preliminary results of a double-blind dose-finding phase II trial.
Bruning PF
Eur J Cancer; 1992; 28A(8-9):1404-7. PubMed ID: 1515258
[TBL] [Abstract][Full Text] [Related]
32. Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene.
Horvath G; Stendahl U; Kalling M; Fernö M; Himmelmann A; Hajba A
Anticancer Res; 1990; 10(2A):323-5. PubMed ID: 2140668
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination].
Chevallier B; Spielmann M; Marty M; Serin D; Pouillart P; Tubiana Hulin M; Mignot L; Pujade Lauraine E; Krams M; Mertens H
Bull Cancer; 1993 Jul; 80(7):624-8. PubMed ID: 8204943
[TBL] [Abstract][Full Text] [Related]
34. High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer.
Gershanovich M; Hayes DF; Ellmén J; Vuorinen J
Oncology (Williston Park); 1997 May; 11(5 Suppl 4):29-36. PubMed ID: 9165504
[TBL] [Abstract][Full Text] [Related]
35. Phase I study of toremifene in patients with advanced cancer.
Hamm JT; Tormey DC; Kohler PC; Haller D; Green M; Shemano I
J Clin Oncol; 1991 Nov; 9(11):2036-41. PubMed ID: 1834808
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
Gylling H; Pyrhönen S; Mäntylä E; Mäenpää H; Kangas L; Miettinen TA
J Clin Oncol; 1995 Dec; 13(12):2900-5. PubMed ID: 8523053
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of toremifene in breast cancer patients. A phase II study.
Valavaara R; Pyrhönen S; Heikkinen M; Rissanen P; Blanco G; Nordman E; Taskinen P; Holsti LR; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):229-31. PubMed ID: 2142240
[TBL] [Abstract][Full Text] [Related]
38. A phase I trial of toremifene, a new antiestrogen.
Hamm JT
Cancer Invest; 1990; 8(2):273-4. PubMed ID: 2144786
[No Abstract] [Full Text] [Related]
39. Alternate antiestrogens and approaches to the prevention of breast cancer.
Jordan VC
J Cell Biochem Suppl; 1995; 22():51-7. PubMed ID: 8538210
[TBL] [Abstract][Full Text] [Related]
40. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]